112 related articles for article (PubMed ID: 28069036)
1. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomas.
Ma Y; Liu L; Yan F; Wei W; Deng J; Sun J
World J Surg Oncol; 2016 Feb; 14(1):41. PubMed ID: 26911892
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
4. MOR1 expression in gastric cancer: a biomarker associated with poor outcome.
Yao YS; Yao RY; Zhuang LK; Qi WW; Lv J; Zhou F; Qiu WS; Yue L
Clin Transl Sci; 2015 Apr; 8(2):137-42. PubMed ID: 25441763
[TBL] [Abstract][Full Text] [Related]
5. NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.
Yoon SO; Kim EK; Lee M; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Oncotarget; 2016 Jan; 7(3):2475-95. PubMed ID: 26673617
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma.
Zhu Y; Yang W; Ji G; Lin N; Wu W; Xiong P; Zheng C; Yan L; Wan P; Wang Y
Oncotarget; 2017 May; 8(19):31092-31100. PubMed ID: 28415703
[TBL] [Abstract][Full Text] [Related]
7. Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers.
Vidal O; Soriano-Izquierdo A; Pera M; Elizalde JI; Palacín A; Castells A; Piqué JM; Volant A; Metges JP
J Gastrointest Surg; 2008 Jun; 12(6):1005-14. PubMed ID: 17972143
[TBL] [Abstract][Full Text] [Related]
8. High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability.
Matson DR; Denu RA; Zasadil LM; Burkard ME; Weaver BA; Flynn C; Stukenberg PT
BMC Cancer; 2021 Feb; 21(1):186. PubMed ID: 33622270
[TBL] [Abstract][Full Text] [Related]
9. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
Dinami R; Porru M; Amoreo CA; Sperduti I; Mottolese M; Buglioni S; Marinelli D; Maugeri-Saccà M; Sacconi A; Blandino G; Leonetti C; Di Rocco G; Verdina A; Spinella F; Fiorentino F; Ciliberto G; Biroccio A; Zizza P
J Exp Clin Cancer Res; 2020 Jun; 39(1):111. PubMed ID: 32539869
[TBL] [Abstract][Full Text] [Related]
10. TPX2: of spindle assembly, DNA damage response, and cancer.
Neumayer G; Belzil C; Gruss OJ; Nguyen MD
Cell Mol Life Sci; 2014 Aug; 71(16):3027-47. PubMed ID: 24556998
[TBL] [Abstract][Full Text] [Related]
11. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
Jiang J; Zhu Y; Wu C; Shen Y; Wei W; Chen L; Zheng X; Sun J; Lu B; Zhang X
Cancer Immunol Immunother; 2010 Nov; 59(11):1707-14. PubMed ID: 20725832
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target.
Zhang M; Huang H; Wei M; Sun M; Deng G; Hu S; Wang H; Gong Y
Curr Cancer Drug Targets; 2024; 24(2):167-177. PubMed ID: 37282642
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer.
Afshar J; Mehrzad J; Mehrad-Majd H; Goshayeshi L; Saeidi J
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2445-2451. PubMed ID: 34452557
[TBL] [Abstract][Full Text] [Related]
15. Endosomal gene expression: a new indicator for prostate cancer patient prognosis?
Johnson IR; Parkinson-Lawrence EJ; Keegan H; Spillane CD; Barry-O'Crowley J; Watson WR; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
Oncotarget; 2015 Nov; 6(35):37919-29. PubMed ID: 26473288
[TBL] [Abstract][Full Text] [Related]
16. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration.
Shi M; Gu Y; Jin K; Fang H; Chen Y; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
Cancer Immunol Immunother; 2021 Jul; 70(7):1831-1840. PubMed ID: 33389016
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of high NPC2 expression in gastric cancer.
Yao Y; Ren J; Lu J; Sui Y; Gong J; Chen X
Sci Rep; 2023 Nov; 13(1):20710. PubMed ID: 38001127
[TBL] [Abstract][Full Text] [Related]
18. The phospholipase PNPLA7 functions as a positive indicator in human colorectal and gastric cancers.
Bai Y; Luo K; Xie W
Medicine (Baltimore); 2023 Oct; 102(42):e35279. PubMed ID: 37861523
[TBL] [Abstract][Full Text] [Related]
19. Structural bioinformatics predicts that the Retinitis Pigmentosa-28 protein of unknown function FAM161A is a homologue of the microtubule nucleation factor Tpx2.
Levine TP
F1000Res; 2020; 9():1052. PubMed ID: 33093951
[No Abstract] [Full Text] [Related]
20.
Huang M; Ma X; Shi H; Hu L; Fan Z; Pang L; Zhu F; Yang X; Xu W; Liu B; Zhu Z; Li C
Oncotarget; 2017 Sep; 8(43):74479-74493. PubMed ID: 29088801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
